Trial
NCT03897491
PD L 506 for Stereotactic Interstitial Photodynamic Therapy of Newly Diagnosed Supratentorial IDH Wild-type Glioblastoma
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
photonamic GmbH & Co. KG
Collaborators
—
Condition
Glioblastoma
Intervention
5-aminolevulinic acid
Why stopped
Low recruitment activities of clinical trial sites.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-06-01